Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Androstane derivatives with activity as pure or predominantly pure stimulators of SERCA2a for the treatment of heart failure

US Patent 12503484 · Granted Dec 23, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →